EUVIMEDEUVIMED entdecken
Crossref

Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy

Yi-Tsung Yang iD, Chi-Yuan Yao iD, Chein-Jun Kao, Po-Ju Chiu, Ming-En Lin, Hsin-An Hou iD, Chien-Chin Lin iD, Wen-Chien Chou iD, Hwei-Fang Tien iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Yi-Tsung Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Alternative Splicing. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Taiwan, National Science and Technology Council, Taiwan, Department of Medical Research, National Taiwan University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant alternative splicing (AS) contributes to leukemogenesis, but reports on the clinical and biological implications of aberrant AS in acute myeloid leukaemia (AML) remain limited. Here, we used RNA‐seq to analyse AS in AML cells from 341 patients, comparing them to healthy CD34 + haematopoietic stem cells (HSCs). Our findings highlight distinct AS patterns in the nuclear transcription factor Y subunit alpha ( NFYA ) gene, with two main isoforms: NFYA ‐L (Long) and NFYA ‐S (Short), differing in exon 3 inclusion. Patients with lower NFYA ‐L but higher NFYA ‐S expression, termed NFYA ‐S predominance, displayed more favourable characteristics and better outcomes following intensive chemotherapy, regardless of age and European LeukemiaNet risk classification, compared to those with higher NFYA ‐L but lower NFYA ‐S expression, termed NFYA ‐L predominance. The prognostic effects were validated using The Cancer Genome Atlas cohort. Transcriptome analysis revealed upregulated cell cycle genes in NFYA ‐S predominant cases, resembling those of active HSCs, demonstrating relative chemosensitivity. Conversely, NFYA ‐L predominant cases, as observed in KMT2A ‐rearranged leukaemia, were associated with relative chemoresistance. NFYA ‐S overexpression in OCI‐AML3 cells promoted cell proliferation, S‐phase entry and increased cytarabine sensitivity, suggesting its clinical and therapeutic relevance in AML. Our study underscores NFYA AS as a potential prognostic biomarker in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteAlternative SplicingHumansFemaleMaleMiddle AgedAdultAgedProtein IsoformsPrognosisCCAAT-Binding FactorClinical Relevance

Stichwörter der Autor:innen

NFYARNA sequencingacute myeloid leukaemiaalternative splicingclinical significance

Substanzen

Protein IsoformsCCAAT-Binding Factor

Autor:innen und Institutionen

  • Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan.
  • Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei City, Taiwan.

ORCID-Profile: Yi-Tsung Yang, Chi-Yuan Yao, Hsin-An Hou, Chien-Chin Lin, Wen-Chien Chou, Hwei-Fang Tien

Förderung

  • Ministry of Health and Welfare, Taiwan
  • National Science and Technology Council, Taiwan
  • Department of Medical Research, National Taiwan University Hospital
  • Ministry of Health and Welfare

Zitieren

APA

Yang, Y. T., Yao, C. Y., Kao, C. J., Chiu, P. J., Lin, M. E., Hou, H. A., Lin, C. C., Chou, W. C., & Tien, H. F. (2024). Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy. British Journal of Haematology. https://doi.org/10.1111/bjh.19733

Vancouver

Yang YT, Yao CY, Kao CJ, Chiu PJ, Lin ME, Hou HA, et al. Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy. British Journal of Haematology. 2024. doi:10.1111/bjh.19733

BibTeX
@article{Yang2024,
  author = {Yang, Yi-Tsung and Yao, Chi-Yuan and Kao, Chein-Jun and Chiu, Po-Ju and Lin, Ming-En and Hou, Hsin-An and Lin, Chien-Chin and Chou, Wen-Chien and Tien, Hwei-Fang},
  title = {Clinical relevance of NFYA splice variants in patients with acute myeloid leukaemia undergoing intensive chemotherapy},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19733}
}
Kostenlos starten →